Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Personalised Assistive Devices Approach for Diabetic Foot Ulcer Prevention

NCT: NCT05236660 · COMPLETED

NCT IDNCT05236660
StatusCOMPLETED
Start Date2022-03-02
Completion2026-03-30

Brief Summary

Preventing foot ulcers in people with diabetes can reduce costs and increase quality of life. Despite availability of various interventions to prevent foot ulcers, recurrence rates remain high. We hypothesise that a multimodal approach incorporating a variety of orthotic interventions that matches an individual person's need can reduce ulcer recurrence with beneficial cost-effectiveness and cost-utility.

Frequently Asked Questions

What is Personalised Assistive Devices Approach for Diabetic Foot Ulcer Prevention?

Personalised Assistive Devices Approach for Diabetic Foot Ulcer Prevention is a clinical trial registered under NCT05236660. Current status: COMPLETED.

What is the status of NCT05236660?

The current status of NCT05236660 (Personalised Assistive Devices Approach for Diabetic Foot Ulcer Prevention) is: COMPLETED.

When did Personalised Assistive Devices Approach for Diabetic Foot Ulcer Prevention start?

Personalised Assistive Devices Approach for Diabetic Foot Ulcer Prevention started on 2022-03-02.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.